Research and Development

Showing 15 posts of 9599 posts found.

Early halt for successful apixaban trial

June 14, 2010 Research and Development apixaban, atrial fibrilation

Pfizer and Bristol-Myers Squibb’s atrial fibrillation treatment apixaban has performed so well in a phase III trial that it has …

Pharma pools trial data for brain disorder research

June 14, 2010 Research and Development Alzheimer's, Huntington's, Parkinson's, clinical trials, partnerships

Leading pharma companies have come together for a major new research collaboration aimed at improving clinical trials for Alzheimer’s, Parkinson’s, …

GSK-funded project will print APIs onto tablets

June 14, 2010 Manufacturing and Production, Research and Development GlaxoSmithKline, manufacturing, production, tablets

Researchers at GlaxoSmithKline and two UK universities are working on a technology that could allow active pharmaceutical ingredients to be …

Chiltern Launches Collaborative Technologies

June 11, 2010 Research and Development

Glenn Kerkhof, Chiltern CEO, commented, “A key benefit of Collaborative Technologies is the immediate access to current study information which …

Zactima promising in rare thyroid cancer

June 11, 2010 Research and Development, Sales and Marketing AstraZeneca, thyroid cancer, zactima

AstraZeneca’s Zactima (vandetanib) will be filed with regulators later this year as a treatment for thyroid cancer after promising results. …

Stem cells and patents: a potent mix

June 10, 2010 Research and Development Stem cells, stem cell

In recent years, there has been much debate about whether or not the use of stem cells in medical research …
Genzyme

Genzyme and Icahn agree compromise deal

June 10, 2010 Research and Development, Sales and Marketing Genzyme

Carl Icahn has won his battle with Genzyme to have his associates given a place on the company’s board.The US …
Blog footer

Digital Pharma: Online clinical collaboration

June 10, 2010 Research and Development biomarkers, digital doctors, digital pharma research, proteomic

A new online educational resource will offer researchers across the medical community access to peer-reviewed information on biomarkers. The portal …

Pfizer appoints neuroscience research head

June 10, 2010 Research and Development Pfizer, appointment, research and development

Pfizer has appointed Dr Michael Ehlers chief scientific officer for neuroscience research. Dr Ehlers most recently served as the George …

‘Stellar’ performance from targeted lung cancer drug

June 9, 2010 Research and Development Pfizer, biomarkers, crizotinib

A new targeted treatment for non small cell lung cancer has produced spectacular results in a sub-group of patients. Pfizer’s …

Nerve gas antidote completes phase I trial

June 9, 2010 Research and Development Protalix, biodefence

Israeli biotech firm Protalix has completed a phase I clinical trial for its intravenous nerve gas antidote. The drug is …

Eisai’s breast cancer drug impresses at ASCO

June 9, 2010 Research and Development ASCO, Eisai, Xeloda, eribulin

A new cancer drug developed by Japanese pharma company Eisai has shown promise in increasing overall survival rates in heavily …

Dr Laurent Audoly joins Pieris

June 9, 2010 Research and Development Pieris, appointment, research and development

French biotech company Pieris has appointed Dr Laurent Audoly as chief scientific officer. Dr Audoly was most recently biologics research …

Merck Serono resubmits oral MS therapy to FDA

June 8, 2010 Research and Development Cladribine, MS, Merck KGaA

Merck Serono has re-submitted its oral multiple sclerosis therapy cladribine to US regulators. Merck Serono, a Swiss division of Merck …

Sanofi to develop monoclonal antibody jabs

June 8, 2010 Research and Development Sanofi Pasteur, Vivalis, vaccines

Sanofi-Aventis is to develop a range of monoclonal antibody for use against infectious diseases. The French pharma company’s vaccines arm …
The Gateway to Local Adoption Series

Latest content